{
  "resourceType" : "ValueSet",
  "id" : "adverse-event-clinical-research-grades",
  "meta" : {
    "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablevalueset"]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet adverse-event-clinical-research-grades</b></p><a name=\"adverse-event-clinical-research-grades\"> </a><a name=\"hcadverse-event-clinical-research-grades\"> </a><a name=\"adverse-event-clinical-research-grades-en-US\"> </a><ul><li>Include these codes as defined in <a href=\"CodeSystem-v3-nciThesaurus.html\"><code>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>C41338</td><td>Grade 1 Mild Adverse Event</td></tr><tr><td>C41339</td><td>Grade 2 Moderate Adverse Event</td></tr><tr><td>C41340</td><td>Grade 3 Severe Adverse Event</td></tr><tr><td>C41337</td><td>Grade 4 Life Threatening or Disabling Adverse Event</td></tr><tr><td>C48275</td><td>Grade 5 Death Related to Adverse Event</td></tr></table></li></ul></div>"
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
    "valueCode" : "brr"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
    "valueInteger" : 1
  }],
  "url" : "http://terminology.hl7.org/ValueSet/adverse-event-clinical-research-grades",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.11.21027"
  }],
  "version" : "1.0.0",
  "name" : "AdverseEventClinicalResearchGrades",
  "title" : "Adverse Event Clinical Research Grades",
  "status" : "active",
  "experimental" : false,
  "date" : "2023-07-28T19:27:19+00:00",
  "publisher" : "Health Level Seven International",
  "contact" : [{
    "telecom" : [{
      "system" : "url",
      "value" : "http://hl7.org"
    },
    {
      "system" : "email",
      "value" : "hq@HL7.org"
    }]
  }],
  "description" : "Value set of grades used in Adverse Event Clinical Research, especially in Oncology clinical trials",
  "copyright" : "This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html",
  "compose" : {
    "include" : [{
      "system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
      "concept" : [{
        "code" : "C41338",
        "display" : "Grade 1 Mild Adverse Event"
      },
      {
        "code" : "C41339",
        "display" : "Grade 2 Moderate Adverse Event"
      },
      {
        "code" : "C41340",
        "display" : "Grade 3 Severe Adverse Event"
      },
      {
        "code" : "C41337",
        "display" : "Grade 4 Life Threatening or Disabling Adverse Event"
      },
      {
        "code" : "C48275",
        "display" : "Grade 5 Death Related to Adverse Event"
      }]
    }]
  }
}